Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Bettin'

<< Previous

Bullboard Posts

Next >>

Comment by CamaroZL1on Feb 02, 2021 3:38pm

64 Views

Post# 32449450

RE:Bettin'

Red~One wrote: I'm saying .59 close and BTW I still don't think hardcore T/A works for volatile Penny stocks, other tools like Charts and Trends are used by Fundamental traders too you know....LOL

And Red are you saying the beta of VXL exceeds that of GME or BB (your other interests) by comparison? They are way more volatile LOL! Let go of your indoctrination bud, but I dont think you, its a long shot.

<< Previous

Bullboard Posts

Next >>

Rising miner increases graphite price, restarts Québec mill